Company · CIK 0001328143
Adamas Pharmaceuticals Inc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AAdamas Pharmaceuticals Inc0001193125-22-042671 · 66.6 KBSEC(opens sec.gov)
- SC 13G/AAdamas Pharmaceuticals Inc0000935836-22-000128 · 61.2 KBSEC(opens sec.gov)
- SC 13G/AAdamas Pharmaceuticals Inc0001493152-22-002255 · 87.8 KBSEC(opens sec.gov)
- SC 13G/AAdamas Pharmaceuticals Inc0000315066-21-001898 · 7.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-143338 · 401.5 KBSEC(opens sec.gov)
- 10-QQuarterly update0001328143-21-000075 · 6.2 MBSEC(opens sec.gov)
- SC 13G/AAdamas Pharmaceuticals Inc0001493152-21-025871 · 112.6 KBSEC(opens sec.gov)
- SC 13DAdamas Pharmaceuticals Inc0001104659-21-127593 · 117.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-21-124979 · 1.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001328143-21-000072 · 260.7 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
1900 POWELL ST., SUITE 1000
EMERYVILLE, CA, 94608
mailing
1900 POWELL ST., SUITE 1000
EMERYVILLE, CA, 94608
Former names
- NeuroMolecular Pharmaceuticals Inc2006-07-17
Same industry